Evidence map›Paper›PMID 39572503›Full record

ArticleThe international journal of cardiovascular imaging2025

Calcific versus non-calcific plaque: a CAD-RADS and FFRCT study.

David Murphy, John Graby, Benjamin Hudson, Robert Lowe, Kevin Carson, Sri Raveen Kandan, Daniel McKenzie, Ali Khavandi, Jonathan Carl Luis Rodrigues

Abstract readComparative Study
In one paragraph

Article in The international journal of cardiovascular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David MurphyCardiology Department, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, Avon, BA1 3NG, UK.
John GrabyCardiology Department, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, Avon, BA1 3NG, UK.
Benjamin HudsonDepartment of Health, University of Bath, Bath, UK.
Robert LoweCardiology Department, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, Avon, BA1 3NG, UK.
Kevin CarsonCardiology Department, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, Avon, BA1 3NG, UK.
Sri Raveen KandanCardiology Department, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, Avon, BA1 3NG, UK.
Daniel McKenzieCardiology Department, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, Avon, BA1 3NG, UK.
Ali KhavandiCardiology Department, Royal United Hospitals Bath NHS Trust, Combe Park, Bath, Avon, BA1 3NG, UK.
Jonathan Carl Luis RodriguesDepartment of Health, University of Bath, Bath, UK. j.rodrigues1@nhs.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary Artery Disease-Reporting and Data System (CAD-RADS) standardises Computed Tomography Coronary Angiography (CTCA) reporting. Coronary calcification can overestimate stenosis. We hypothesized where CADRADS category is assigned due to predominantly calcified maximal stenosis (Ca+), the CTCA-derived Fractional Flow Reserve (FFRCT) would be lower compared to predominantly non-calcified maximal stenoses (Ca-) of the same CAD-RADS category. Consecutive patients undergoing routine clinical CTCA (September 2018 to May 2020) with ≥1 stenosis ≥25% with FFRCT correlation were included. CTCA's were subdivided into Ca+ and Ca-. FFRCT was measured in the left anterior descending (LAD), left circumflex (LCx) and right coronary artery (RCA). Potentially flow-limiting classified as FFRCT≤0.8. A subset had Invasive Coronary Angiography (ICA). 561 patients screened, 320 included (60% men, 69±10 years). Ca+ in 51%, 69% and 50% of CAD-RADS 2, 3 and 4 respectively. There was no difference in the prevalence of FFRCT≤0.8 between Ca+ and Ca- stenoses for each CAD-RADS categories. No difference was demonstrated in the median maximal stenoses FFRCT or end-vessel FFRCT within CAD-RADS 2 and 4. CAD-RADS 3 Ca+ had a lower FFRCT (maximal stenosis p= .02, end-vessel p= .005) vs Ca-. No difference in the prevalence of obstructive disease at ICA between predominantly Ca+ and Ca- for any CAD-RADS category. There was no difference in median FFRCT values or rate of obstructive disease at ICA between Ca+ and Castenosis in both CAD-RADS 2 and 4. Ca+ CAD-RADS 3 was suggestive of an underestimation based on FFRCT but not corroborated at ICA.

Indexed as

Computed Tomography AngiographyCoronary AngiographyCoronary Artery DiseaseCoronary StenosisCoronary VesselsFractional Flow Reserve, MyocardialPlaque, AtheroscleroticVascular CalcificationAgedFemaleHumansMaleMiddle AgedPredictive Value of TestsReproducibility of ResultsRetrospective StudiesCalcific coronary artery diseaseChronic coronary syndromeCoputed tomorgaphy coronary angiography

Identifiers

PMID39572503
PMCPMC11741995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.